These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 4847311)

  • 1. Skeletal muscle: reservoir for exogenous L-dopa.
    Ordonez LA; Arbrus M; Boyson S; Goodman MN; Ruderman NB; Wurtman RJ
    J Pharmacol Exp Ther; 1974 Jul; 190(1):187-91. PubMed ID: 4847311
    [No Abstract]   [Full Text] [Related]  

  • 2. Increased glucose and 2-deoxy-D-glucose uptake in skeletal muscle of suspended rats.
    Koebel DA; Fell RD; Steffen JM
    Aviat Space Environ Med; 1993 Nov; 64(11):1016-22. PubMed ID: 8280034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methylation of exogenous 3,4-dihydroxyphenylalanine (,dopa)--effects on methyl group metabolism.
    Ordonez LA; Wurtman RJ
    Biochem Pharmacol; 1973 Jan; 22(1):134-7. PubMed ID: 4763241
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of L-dopa on accumulation and efflux of monoamines in particles of rat brain homogenates.
    Ng LK; Colburn RW; Kopin IJ
    J Pharmacol Exp Ther; 1972 Nov; 183(2):316-25. PubMed ID: 5083548
    [No Abstract]   [Full Text] [Related]  

  • 5. Regional effects of L-dihydroxyphenylalanine (L-dopa) on norepinephrine metabolism in rat brain.
    Romero JA; Chalmers JP; Cottman K; Lytle LD; Wurtman RJ
    J Pharmacol Exp Ther; 1972 Feb; 180(2):277-85. PubMed ID: 5010674
    [No Abstract]   [Full Text] [Related]  

  • 6. Acetyl-L-carnitine dietary supplementation to old rats increases mitochondrial transcription factor A content in rat hindlimb skeletal muscles.
    Pesce V; Fracasso F; Musicco C; Lezza AM; Cantatore P; Gadaleta MN
    Ann N Y Acad Sci; 2004 Jun; 1019():430-3. PubMed ID: 15247059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. L-dopa therapy in parkinsonism: mechanism of action.
    Sandler M
    Psychiatr Neurol Neurochir; 1971; 74(4):331-3. PubMed ID: 5146239
    [No Abstract]   [Full Text] [Related]  

  • 8. [Fixation and dissociation of insulin in peripheral tissue during rest and exertion. Studies on the perfused hindlimb of the rat].
    Dieterle C; Oberndorfer H; Dieterle P
    Verh Dtsch Ges Inn Med; 1974; 80():1308-11. PubMed ID: 4454407
    [No Abstract]   [Full Text] [Related]  

  • 9. [Adrenaline, noradrenaline, dopamine and DOPA in the blood and other tissues of white rats following cranio-cerebral injury].
    Matlina ESh; Rakhmanova TB
    Biull Eksp Biol Med; 1967 Mar; 63(3):55-7. PubMed ID: 5622344
    [No Abstract]   [Full Text] [Related]  

  • 10. Cerebral accumulation and metabolism of C14-dopa after selective inhibition of peripheral decarboxylase.
    Bartholini G; Pletscher A
    J Pharmacol Exp Ther; 1968 May; 161(1):14-20. PubMed ID: 5648492
    [No Abstract]   [Full Text] [Related]  

  • 11. Modification of the cardiovascular effects of L-dopa by decarboxylase inhibitors.
    Watanabe AM; Parks LC; Kopin IJ
    J Clin Invest; 1971 Jun; 50(6):1322-8. PubMed ID: 5578236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. On the behavioral and neurochemical actions of 6-hydroxydopa and 5,6-dihydroxytryptamine in rats.
    Richardson JS; Cowan N; Hartman R; Jacobowitz DM
    Res Commun Chem Pathol Pharmacol; 1974 May; 8(1):29-44. PubMed ID: 4847904
    [No Abstract]   [Full Text] [Related]  

  • 13. Time-dependent changes in brain 3 H-norepinephrine disappearance caused by L-DOPA administration.
    Hyyppä MT; Wurtman RJ
    Life Sci I; 1972 Aug; 11(15):713-21. PubMed ID: 4678968
    [No Abstract]   [Full Text] [Related]  

  • 14. Central receptor activity of amines formed from L-dopa and some dopa analogs.
    Andén NE; Butcher SG; Engel J
    Acta Pharmacol Toxicol (Copenh); 1970; 28(1):30. PubMed ID: 5314408
    [No Abstract]   [Full Text] [Related]  

  • 15. [Biochemical bases for the treatment of Parkinson's syndrome with L-dopa].
    Pletscher A; Bartholini G; Gey KF; Jenni A
    Schweiz Med Wochenschr; 1970 May; 100(19):797-804. PubMed ID: 4924275
    [No Abstract]   [Full Text] [Related]  

  • 16. L-DOPA and dopamine on skeletal muscle.
    Ferko AP; Calesnick B
    Res Commun Chem Pathol Pharmacol; 1971 Mar; 2(2):146-53. PubMed ID: 5149882
    [No Abstract]   [Full Text] [Related]  

  • 17. [3H]DOPA formed from [3H]tyrosine in living rat brain is not committed to dopamine synthesis.
    Cumming P; Ase A; Kuwabara H; Gjedde A
    J Cereb Blood Flow Metab; 1998 May; 18(5):491-9. PubMed ID: 9591841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blockade of L-dopa reversal of reserpine-induced conditioned avoidance response suppression by disulfiram.
    Seiden LS; Peterson DD
    J Pharmacol Exp Ther; 1968 Sep; 163(1):84-90. PubMed ID: 5673718
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effect of aminazin on the content of adrenaline, nordrenaline, dopamine and dopa in rat tissue in closed cranio-cerebral trauma].
    Matlina ESh; Rakhmanova TB
    Farmakol Toksikol; 1969; 32(2):138-40. PubMed ID: 5772133
    [No Abstract]   [Full Text] [Related]  

  • 20. Amino acid and dopa levels in plasma and urine from L-dopa-treated patients with Parkinson's disease.
    Hare TA; Vanna S; Beasley B; Chambers R; Vogel WH
    J Lab Clin Med; 1971 Feb; 77(2):319-25. PubMed ID: 5540775
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.